Immuno Oncology Assays Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Immunoassays, PCR, NGS, Flow Cytometry, Others); Indication (Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, Others); Application (Clinical Diagnostics, Research)

Report Code: TIPRE00006575 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Immuno oncology assays include the use of various immunology assays to monitor the interaction between immune cells and cancer cells. The human body's immune system has a great potential to destroy tumor cells producing no toxicity to normal cells. Moreover, the immune system also can prevent the recurrence of cancer.

MARKET SCOPE

The "Global Immuno Oncology Assays Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the immuno oncology assays market with detailed market segmentation by technology, indication, application, and geography. The report provides key statistics on the market status of the leading immuno oncology assays market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on technology, the global immuno oncology assays market is segmented into immunoassays, PCR, NGS, flow cytometry, others.
  •   Based on indication, the global immuno oncology assays market is segmented into colorectal cancer, lung cancer, melanoma, bladder cancer, others
  •   Based on application, the market is bifurcated into clinical diagnostics, research.
    ?

MARKET DYNAMICS
Drivers:

  •   Rising incidence of cancer and growing adoption of targeted therapies
  •   Increased demand for personalized medicine
  •   Growing patient preference towards immunotherapies and immunodiagnostics

Restraints:

  •   Requirement of high capital investments and low cost-benefit ratio
  •   Unfavorable regulatory and reimbursement scenario
  •   High cost of immunotherapy



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The immuno oncology assays market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the immuno oncology assays market in these regions.

IMPACT OF COVID-19 ON IMMUNO ONCOLOGY ASSAYS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Numerous patients pretended with COVID-19 were people with malignancies. Investigation in this area is further undertaken to understand better the infection dynamics, which is expected to drive the cancer research field. The shift in demand for research on COVID-19 and oncology has created considerable scope for testing solutions, such as assays and profiling panel testing outcomes. This is further anticipated to drive the demand for immuno-oncology assays and instruments.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the immuno oncology assays market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from immuno oncology assays market are anticipated to lucrative growth opportunities in the future with the rising demand for immuno oncology assays in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the immuno oncology assays market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Agilent Technologies, Inc.
  •   F. Hoffmann-La Roche Ltd
  •   HTG Molecular Diagnostics, Inc.
  •   Illumina, Inc.
  •   Merck KGaA
  •   PerkinElmer Inc.
  •   Thermo Fisher Scientific Inc.
  •   Qiagen
  •   Sartorius AG
  •   NanoString Technologies, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Immuno Oncology Assays Market - By Technology
1.3.2 Immuno Oncology Assays Market - By Indication
1.3.3 Immuno Oncology Assays Market - By Application
1.3.4 Immuno Oncology Assays Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IMMUNO ONCOLOGY ASSAYS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IMMUNO ONCOLOGY ASSAYS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IMMUNO ONCOLOGY ASSAYS MARKET - GLOBAL MARKET ANALYSIS
6.1. IMMUNO ONCOLOGY ASSAYS - GLOBAL MARKET OVERVIEW
6.2. IMMUNO ONCOLOGY ASSAYS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. IMMUNO ONCOLOGY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. IMMUNOASSAYS
7.3.1. Overview
7.3.2. Immunoassays Market Forecast and Analysis
7.4. PCR
7.4.1. Overview
7.4.2. PCR Market Forecast and Analysis
7.5. NGS
7.5.1. Overview
7.5.2. NGS Market Forecast and Analysis
7.6. FLOW CYTOMETRY
7.6.1. Overview
7.6.2. Flow Cytometry Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. IMMUNO ONCOLOGY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. COLORECTAL CANCER
8.3.1. Overview
8.3.2. Colorectal Cancer Market Forecast and Analysis
8.4. LUNG CANCER
8.4.1. Overview
8.4.2. Lung Cancer Market Forecast and Analysis
8.5. MELANOMA
8.5.1. Overview
8.5.2. Melanoma Market Forecast and Analysis
8.6. BLADDER CANCER
8.6.1. Overview
8.6.2. Bladder Cancer Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. IMMUNO ONCOLOGY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CLINICAL DIAGNOSTICS
9.3.1. Overview
9.3.2. Clinical Diagnostics Market Forecast and Analysis
9.4. RESEARCH
9.4.1. Overview
9.4.2. Research Market Forecast and Analysis
10. IMMUNO ONCOLOGY ASSAYS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Immuno Oncology Assays Market Overview
10.1.2 North America Immuno Oncology Assays Market Forecasts and Analysis
10.1.3 North America Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.1.4 North America Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.1.5 North America Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.1.6 North America Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.1.6.1 United States Immuno Oncology Assays Market
10.1.6.1.1 United States Immuno Oncology Assays Market by Technology
10.1.6.1.2 United States Immuno Oncology Assays Market by Indication
10.1.6.1.3 United States Immuno Oncology Assays Market by Application
10.1.6.2 Canada Immuno Oncology Assays Market
10.1.6.2.1 Canada Immuno Oncology Assays Market by Technology
10.1.6.2.2 Canada Immuno Oncology Assays Market by Indication
10.1.6.2.3 Canada Immuno Oncology Assays Market by Application
10.1.6.3 Mexico Immuno Oncology Assays Market
10.1.6.3.1 Mexico Immuno Oncology Assays Market by Technology
10.1.6.3.2 Mexico Immuno Oncology Assays Market by Indication
10.1.6.3.3 Mexico Immuno Oncology Assays Market by Application
10.2. EUROPE
10.2.1 Europe Immuno Oncology Assays Market Overview
10.2.2 Europe Immuno Oncology Assays Market Forecasts and Analysis
10.2.3 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.2.4 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.2.5 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.2.6 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Immuno Oncology Assays Market
10.2.6.1.1 Germany Immuno Oncology Assays Market by Technology
10.2.6.1.2 Germany Immuno Oncology Assays Market by Indication
10.2.6.1.3 Germany Immuno Oncology Assays Market by Application
10.2.6.2 France Immuno Oncology Assays Market
10.2.6.2.1 France Immuno Oncology Assays Market by Technology
10.2.6.2.2 France Immuno Oncology Assays Market by Indication
10.2.6.2.3 France Immuno Oncology Assays Market by Application
10.2.6.3 Italy Immuno Oncology Assays Market
10.2.6.3.1 Italy Immuno Oncology Assays Market by Technology
10.2.6.3.2 Italy Immuno Oncology Assays Market by Indication
10.2.6.3.3 Italy Immuno Oncology Assays Market by Application
10.2.6.4 Spain Immuno Oncology Assays Market
10.2.6.4.1 Spain Immuno Oncology Assays Market by Technology
10.2.6.4.2 Spain Immuno Oncology Assays Market by Indication
10.2.6.4.3 Spain Immuno Oncology Assays Market by Application
10.2.6.5 United Kingdom Immuno Oncology Assays Market
10.2.6.5.1 United Kingdom Immuno Oncology Assays Market by Technology
10.2.6.5.2 United Kingdom Immuno Oncology Assays Market by Indication
10.2.6.5.3 United Kingdom Immuno Oncology Assays Market by Application
10.2.6.6 Rest of Europe Immuno Oncology Assays Market
10.2.6.6.1 Rest of Europe Immuno Oncology Assays Market by Technology
10.2.6.6.2 Rest of Europe Immuno Oncology Assays Market by Indication
10.2.6.6.3 Rest of Europe Immuno Oncology Assays Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Immuno Oncology Assays Market Overview
10.3.2 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis
10.3.3 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Immuno Oncology Assays Market
10.3.6.1.1 Australia Immuno Oncology Assays Market by Technology
10.3.6.1.2 Australia Immuno Oncology Assays Market by Indication
10.3.6.1.3 Australia Immuno Oncology Assays Market by Application
10.3.6.2 China Immuno Oncology Assays Market
10.3.6.2.1 China Immuno Oncology Assays Market by Technology
10.3.6.2.2 China Immuno Oncology Assays Market by Indication
10.3.6.2.3 China Immuno Oncology Assays Market by Application
10.3.6.3 India Immuno Oncology Assays Market
10.3.6.3.1 India Immuno Oncology Assays Market by Technology
10.3.6.3.2 India Immuno Oncology Assays Market by Indication
10.3.6.3.3 India Immuno Oncology Assays Market by Application
10.3.6.4 Japan Immuno Oncology Assays Market
10.3.6.4.1 Japan Immuno Oncology Assays Market by Technology
10.3.6.4.2 Japan Immuno Oncology Assays Market by Indication
10.3.6.4.3 Japan Immuno Oncology Assays Market by Application
10.3.6.5 South Korea Immuno Oncology Assays Market
10.3.6.5.1 South Korea Immuno Oncology Assays Market by Technology
10.3.6.5.2 South Korea Immuno Oncology Assays Market by Indication
10.3.6.5.3 South Korea Immuno Oncology Assays Market by Application
10.3.6.6 Rest of Asia-Pacific Immuno Oncology Assays Market
10.3.6.6.1 Rest of Asia-Pacific Immuno Oncology Assays Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Immuno Oncology Assays Market by Indication
10.3.6.6.3 Rest of Asia-Pacific Immuno Oncology Assays Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Immuno Oncology Assays Market Overview
10.4.2 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis
10.4.3 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Immuno Oncology Assays Market
10.4.6.1.1 South Africa Immuno Oncology Assays Market by Technology
10.4.6.1.2 South Africa Immuno Oncology Assays Market by Indication
10.4.6.1.3 South Africa Immuno Oncology Assays Market by Application
10.4.6.2 Saudi Arabia Immuno Oncology Assays Market
10.4.6.2.1 Saudi Arabia Immuno Oncology Assays Market by Technology
10.4.6.2.2 Saudi Arabia Immuno Oncology Assays Market by Indication
10.4.6.2.3 Saudi Arabia Immuno Oncology Assays Market by Application
10.4.6.3 U.A.E Immuno Oncology Assays Market
10.4.6.3.1 U.A.E Immuno Oncology Assays Market by Technology
10.4.6.3.2 U.A.E Immuno Oncology Assays Market by Indication
10.4.6.3.3 U.A.E Immuno Oncology Assays Market by Application
10.4.6.4 Rest of Middle East and Africa Immuno Oncology Assays Market
10.4.6.4.1 Rest of Middle East and Africa Immuno Oncology Assays Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Immuno Oncology Assays Market by Indication
10.4.6.4.3 Rest of Middle East and Africa Immuno Oncology Assays Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Immuno Oncology Assays Market Overview
10.5.2 South and Central America Immuno Oncology Assays Market Forecasts and Analysis
10.5.3 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.5.6 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Immuno Oncology Assays Market
10.5.6.1.1 Brazil Immuno Oncology Assays Market by Technology
10.5.6.1.2 Brazil Immuno Oncology Assays Market by Indication
10.5.6.1.3 Brazil Immuno Oncology Assays Market by Application
10.5.6.2 Argentina Immuno Oncology Assays Market
10.5.6.2.1 Argentina Immuno Oncology Assays Market by Technology
10.5.6.2.2 Argentina Immuno Oncology Assays Market by Indication
10.5.6.2.3 Argentina Immuno Oncology Assays Market by Application
10.5.6.3 Rest of South and Central America Immuno Oncology Assays Market
10.5.6.3.1 Rest of South and Central America Immuno Oncology Assays Market by Technology
10.5.6.3.2 Rest of South and Central America Immuno Oncology Assays Market by Indication
10.5.6.3.3 Rest of South and Central America Immuno Oncology Assays Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. IMMUNO ONCOLOGY ASSAYS MARKET, KEY COMPANY PROFILES
13.1. AGILENT TECHNOLOGIES, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. F. HOFFMANN-LA ROCHE LTD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. HTG MOLECULAR DIAGNOSTICS, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ILLUMINA, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MERCK KGAA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. PERKINELMER INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. THERMO FISHER SCIENTIFIC INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. QIAGEN
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SARTORIUS AG
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NANOSTRING TECHNOLOGIES, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Agilent Technologies, Inc.
2. F. Hoffmann-La Roche Ltd
3. HTG Molecular Diagnostics, Inc.
4. Illumina, Inc.
5. Merck KGaA
6. PerkinElmer Inc.
7. Thermo Fisher Scientific Inc.
8. Qiagen
9. Sartorius AG
10. NanoString Technologies, Inc.
11. Biomerieux SA
12. Myriad Genetics, Inc.
13. Guardant Health, Inc.
14. Bio-Rad Laboratories, Inc.
15. Seegene Inc.
16. Meso Scale Diagnostics, LLC
17. Olink
18. Asuragen, Inc.
19. Invivoscribe, Inc.
20. Creative Biolabs
TIPRE00006575
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking